InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient de ...

If you are part of the Venn diagram overlap of people who love both the nightmare-inducing ghosts of Phasmophobia and the surreal world of troubled author Alan Wake, then good news because a ...

(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...

The alternative pathway (AP) plays a crucial role in triggering complement activation and promoting chronic inflammation. This study aims to investigate the longitudinal association between AP and ...

Requirement Analysis: Identified the core operations required for the ALU: addition, subtraction, AND, OR, and NOT. Defined input and output specifications for the ALU. Two inputs A and B for binary ...

Mateo Kovacic scored twice for Manchester City as they came from behind to beat Fulham 3-2 at the Etihad Stadium. The Croatian struck either side of half-time after Andreas Pereira had given the ...